US 9,663,478 B2Granted

Benzotriazine oxides as drugs targeting Mycobacterium tuberculosis

AssigneeSRI International

InventorsPeter Madrid, Sidharth Chopra, Kenneth Ryan, Gary Koolpe

Life of this patent

Estimating the term…

Benzotriazine doxides are disclosed as drugs targeting mycobacterium tuberculosis, including novel compounds of formula I:

Dependent claims

A compound of having a structure selected from the following table:

Dependencies are inferred from the claim text.

C07D 253/10
Condensed with carbocyclic rings or ring systems: condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
A61K 31/53
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with three nitrogens as the only ring hetero…
A61K 31/5377
1,4-Oxazines, e.g. morpholine: not condensed and containing further heterocyclic rings, e.g. timolol
A61K 31/541
Having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame: non-condensed thiazines containing…

From the US filing history. Foreign family members aren’t listed.

Loading patent…